Xiao-Ying Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Xiao-Ying Li has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Baosen Zhou
Department of Clinical Epidemiology and Center of Evidence Based Medicine, The First Hospital of China Medical University, Shenyang, China
1 shared publication - Dong-Hui Huang
Department of Clinical Epidemiology, Shengjing Hospital of China Medical University, Shenyang, China
1 shared publication - Jia-Xin Liu1 shared publication
- Jia-Yi Wang1 shared publication
- Jin Xu1 shared publication
- Ke-Xin Liu1 shared publication
Latest Publications
- Open Access
- 11 January 2025
- Published by Wiley in Depression and Anxiety
- Vol. 2025 (1)
Individual and Joint Associations of Depression‐Related Symptoms and Sleep Quality With Overall Survival Among Patients With Ovarian Cancer: Evidence From a Prospective Cohort Study
Background: As the evidence linking depression and sleep quality to overall survival (OS) is lacking, we aim to evaluate the individual and joint associations of depression‐related symptoms and sleep quality with OS among patients with ovarian cancer (OC). Method: A total of 554 patients with OC were included. Depression‐related symptoms and sleep quality were measured using the Patient Health Questionnaire (PHQ‐9) and the Pittsburgh Sleep Quality Index (PSQI). The primary analysis utilized the average levels of depression‐related symptoms and sleep quality by averages of PSQI score and PHQ score between pre‐diagnosis and post‐diagnosis. Deaths were ascertained until February 16, 2023, via medical records and active follow‐up. Cox proportional hazard regression was used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) of the joint and individual associations of sleep quality and depression‐related symptoms with OC survival. Result: A total of 205 deaths occurred during a median follow‐up of 44.6 months. The average level of depression‐related symptoms and sleep quality were independently associated with OS (HR depression vs. no depression = 1.55, 95% CI = 1.10–2.17; HR poor sleep vs. good sleep = 2.05, 95% CI = 1.51–2.75). We documented multiplicative and additive interactions between these two factors in relation to OS ( P interaction < 0.01; relative excess risk due to interaction = 0.16, 95% CI = 0.01–0.31). Combinations of depression‐related symptoms and poor sleep quality were positively associated with OC mortality (HR = 2.61, 95% CI = 1.70–4.00), compared to patients with good sleep quality and without depression‐related symptoms. Conclusion: Poor OC survival was observed among patients with poor sleep quality and depression‐related symptoms, independently and jointly.
- 11 January 2025
- Published by Wiley in Depression and Anxiety
- Vol. 2025 (1)
Open AccessIndividual and Joint Associations of Depression‐Related Symptoms and Sleep Quality With Overall Survival Among Patients With Ovarian Cancer: Evidence From a Prospective Cohort Study
Background: As the evidence linking depression and sleep quality to overall survival (OS) is lacking, we aim to evaluate the individual and joint associations of depression‐related symptoms and sleep quality with OS among patients with ovarian cancer (OC). Method: A total of 554 patients with OC were included. Depression‐related symptoms and sleep quality were measured using the Patient Health Questionnaire (PHQ‐9) and the Pittsburgh Sleep Quality Index (PSQI). The primary analysis utilized the average levels of depression‐related symptoms and sleep quality by averages of PSQI score and PHQ score between pre‐diagnosis and post‐diagnosis. Deaths were ascertained until February 16, 2023, via medical records and active follow‐up. Cox proportional hazard regression was used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) of the joint and individual associations of sleep quality and depression‐related symptoms with OC survival. Result: A total of 205 deaths occurred during a median follow‐up of 44.6 months. The average level of depression‐related symptoms and sleep quality were independently associated with OS (HR depression vs. no depression = 1.55, 95% CI = 1.10–2.17; HR poor sleep vs. good sleep = 2.05, 95% CI = 1.51–2.75). We documented multiplicative and additive interactions between these two factors in relation to OS ( P interaction < 0.01; relative excess risk due to interaction = 0.16, 95% CI = 0.01–0.31). Combinations of depression‐related symptoms and poor sleep quality were positively associated with OC mortality (HR = 2.61, 95% CI = 1.70–4.00), compared to patients with good sleep quality and without depression‐related symptoms. Conclusion: Poor OC survival was observed among patients with poor sleep quality and depression‐related symptoms, independently and jointly.
- Open Access
- 28 June 2018
- Published by Wiley in BioMed Research International
- Vol. 2018, 1-14
Clinically Correlated MicroRNAs in the Diagnosis of Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
(1) Background. Non-small cell lung cancer (NSCLC) has a high mortality rate. MiRNAs have been found to be diagnostic biomarkers for NSCLC. However, controversial results exist. We conducted this meta-analysis to evaluate the diagnostic value of miRNAs for NSCLC.(2) Methods. Databases and reference lists were searched. Pooled sensitivity (SEN), specificity (SPE), and area under the curve (AUC) were applied to examine the general diagnostic efficacy, and subgroup analysis was also performed.(3) Results. Pooled SEN, SPE, and AUC were 85%, 88%, and 0.93, respectively, for 71 studies. Multiple miRNAs (AUC: 0.96) obtained higher diagnostic value than single miRNA (AUC: 0.86), and the same result was found for Caucasian population (AUC: 0.97) when compared with Asian (AUC: 0.91) and Caucasian/African population (AUC: 0.92). MiRNA had higher diagnostic efficacy when participants contained both smokers and nonsmokers (AUC is 0.95 for imbalanced group and 0.91 for balanced group) than when containing only smokers (AUC: 0.90). Meanwhile, AUC was 0.91 for both miR-21 and miR-210.(4) Conclusions. Multiple miRNAs such as miR-21 and miR-210 could be used as diagnostic tools for NSCLC, especially for the Caucasian and nonsmoking NSCLC.
- 28 June 2018
- Published by Wiley in BioMed Research International
- Vol. 2018, 1-14
Open AccessClinically Correlated MicroRNAs in the Diagnosis of Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
(1) Background. Non-small cell lung cancer (NSCLC) has a high mortality rate. MiRNAs have been found to be diagnostic biomarkers for NSCLC. However, controversial results exist. We conducted this meta-analysis to evaluate the diagnostic value of miRNAs for NSCLC.(2) Methods. Databases and reference lists were searched. Pooled sensitivity (SEN), specificity (SPE), and area under the curve (AUC) were applied to examine the general diagnostic efficacy, and subgroup analysis was also performed.(3) Results. Pooled SEN, SPE, and AUC were 85%, 88%, and 0.93, respectively, for 71 studies. Multiple miRNAs (AUC: 0.96) obtained higher diagnostic value than single miRNA (AUC: 0.86), and the same result was found for Caucasian population (AUC: 0.97) when compared with Asian (AUC: 0.91) and Caucasian/African population (AUC: 0.92). MiRNA had higher diagnostic efficacy when participants contained both smokers and nonsmokers (AUC is 0.95 for imbalanced group and 0.91 for balanced group) than when containing only smokers (AUC: 0.90). Meanwhile, AUC was 0.91 for both miR-21 and miR-210.(4) Conclusions. Multiple miRNAs such as miR-21 and miR-210 could be used as diagnostic tools for NSCLC, especially for the Caucasian and nonsmoking NSCLC.